AKAM
50
7
NUE
58
7
MTCH
42
5
SWKS
49
11
RL
68
3
CI
52
7
ICE
62
3
MTB
65
2
RIG
58
4
SWK
61
5
LEN
52
2
HPQ
57
-2
SLG
66
2
BK
72
4
DOW
34
4
GILD
49
2
EMC
53
5
FOXA
59
4
RRC
59
-4
FE
52
3
AKAM
50
7
NUE
58
7
MTCH
42
5
SWKS
49
11
RL
68
3
CI
52
7
ICE
62
3
MTB
65
2
RIG
58
4
SWK
61
5
LEN
52
2
HPQ
57
-2
SLG
66
2
BK
72
4
DOW
34
4
GILD
49
2
EMC
53
5
FOXA
59
4
RRC
59
-4
FE
52
3
Financhill
Back

ANI Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

ANIP
ANI Pharmaceuticals

Last Price:
55.82
Seasonality Move:
6.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

ANI Pharmaceuticals Price Quote

$55.82
-0.04 (1.31%)
(Updated: November 22, 2024 at 5:11 AM ET)

ANI Pharmaceuticals Key Stats

Sell
30
ANI Pharmaceuticals (ANIP) is a Sell
Day range:
$54.75 - $56.38
52-week range:
$48.20 - $70.81
Dividend yield:
0%
P/E ratio:
65.72
P/S ratio:
1.95
P/B ratio:
2.89%
Volume:
181.9K
Avg. volume:
248.7K
1-year change:
7.82%
Market cap:
$1.2B
Revenue:
$486.8M
EPS:
$-0.57

How Much Does ANI Pharmaceuticals Make?

Is ANI Pharmaceuticals Growing As A Company?

  • What Is ANI Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.13%
  • What Is ANI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ANI Pharmaceuticals Stock Price Performance

What Is ANI Pharmaceuticals 52-Week High & Low?

ANI Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy ANI Pharmaceuticals?

Is ANI Pharmaceuticals Cash Flow Positive?

  • What Is ANIP Cash Flow From Operations?
    Cash flow from operations (TTM) is $92.9M
  • What Is ANI Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $257.9M
  • What Is ANI Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$398.8M

ANI Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ANIP return on invested capital is -0.87%
  • What Is ANI Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -0.72%
  • What Is ANIP Return On Equity?
    ROE is a measure of profitability and is -1.54%

ANI Pharmaceuticals Earnings Date & Stock Price

ANI Pharmaceuticals Competitors

  • Who Are ANI Pharmaceuticals's Competitors?
    Below is a list of companies who compete with ANI Pharmaceuticals or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Allogene Therapeutics Inc (ALLO)
    • Armata Pharmaceuticals Inc (ARMP)
    • Protalix BioTherapeutics Inc (PLX)
    • Windtree Therapeutics Inc (WINT)

ANI Pharmaceuticals Dividend Yield

ANI Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 23.39%
Revenue: 12.52% 2.74%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 78.40
Upside from Last Price: 40.35%

Major Shareholders

  • How many ANIP shares are owned by institutional investors?
    23.8M ANIP shares are owned by institutional investors
  • How many ANIP shares are owned by insiders?
    2.7M ANIP shares are owned by insiders